These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34387164)

  • 1. New Insights into Ocular Complications of Human Immunodeficiency Virus Infection.
    Wang L; Che X; Jiang J; Qian Y; Wang Z
    Curr HIV Res; 2021; 19(6):476-487. PubMed ID: 34387164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus and intraocular inflammation in the era of highly active anti retroviral therapy - An update.
    Sudharshan S; Nair N; Curi A; Banker A; Kempen JH
    Indian J Ophthalmol; 2020 Sep; 68(9):1787-1798. PubMed ID: 32823395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
    Mowatt L
    West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninfectious pulmonary complications of HIV/AIDS.
    Kanmogne GD
    Curr Opin Pulm Med; 2005 May; 11(3):208-12. PubMed ID: 15818181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
    Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
    JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular manifestations of HIV infection.
    Jabs DA
    Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reviewing the oral pigmented lesions of human immunodeficiency virus with emphasis on the effect of highly active antiretroviral therapy.
    Varadarajan S; Balaji TM; Kumar S N; Indu Bharkavi SK; Thangavel G; Raj AT; Patil S; Al-Iryani GM; Ali FM; Awan KH
    Dis Mon; 2021 Sep; 67(9):101167. PubMed ID: 33640179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
    Mukhtar F; Ilozumba M; Utuama O; Cimenler O
    JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy.
    Sudharshan S; Menia NK; Selvamuthu P; Tyagi M; Kumarasamy N; Biswas J
    Indian J Ophthalmol; 2020 Sep; 68(9):1887-1893. PubMed ID: 32823409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.
    Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Manifestations of Human Immunodeficiency Virus Infection at a Tertiary Referral Center in Taiwan.
    Tsen CL; Chen YS; Wu KS; Tsai HC; Chen YH; Lee YY; Sheu SJ
    Ocul Immunol Inflamm; 2019; 27(7):1071-1076. PubMed ID: 30189150
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on opportunistic infections in the era of effective antiretroviral therapy.
    Zanoni BC; Gandhi RT
    Infect Dis Clin North Am; 2014 Sep; 28(3):501-18. PubMed ID: 25151568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunistic disorders of the gastrointestinal tract in the age of highly active antiretroviral therapy.
    Huppmann AR; Orenstein JM
    Hum Pathol; 2010 Dec; 41(12):1777-87. PubMed ID: 21078437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmasked Kaposi and sarcoidosis immune reconstitution inflammatory syndrome in a patient with AIDS.
    Salto JN; Volkow P; Herrera-Goepfert R; López-Garcia AI; Cortes-Garcia BY; García-Pérez FO; Arroyo-Hernandez M; Rivera-Rosales RM
    AIDS; 2024 May; 38(6):933-934. PubMed ID: 38578965
    [No Abstract]   [Full Text] [Related]  

  • 20. Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS.
    Yen YF; Chen M; Jen IA; Chuang PH; Lee CY; Lin SI; Chen YA
    Sci Rep; 2019 Mar; 9(1):3476. PubMed ID: 30837537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.